Colgate-Palmolive (NYSE:CL) COO Panagiotis Tsourapas Sells 15,000 Shares

Colgate-Palmolive Company (NYSE:CL) COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the transaction, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. This represents a 59.02% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Panagiotis Tsourapas also recently made the following trade(s):

• On Wednesday, February 11th, Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL traded up $0.44 during trading hours on Friday, hitting $96.61. The stock had a trading volume of 5,148,337 shares, compared to its average volume of 7,565,393. The firm has a market capitalization of $77.87 billion, a price-to-earnings ratio of 36.87, a PEG ratio of 4.30 and a beta of 0.29. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The stock’s fifty day simple moving average is $83.43 and its 200 day simple moving average is $81.83.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the prior year, the firm posted $0.91 EPS. Colgate-Palmolive’s revenue was up 5.8% compared to the same quarter last year. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Hedge Funds Weigh In On Colgate-Palmolive

Institutional investors have recently made changes to their positions in the business. Westside Investment Management Inc. grew its stake in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after acquiring an additional 130 shares during the last quarter. CBIZ Investment Advisory Services LLC boosted its holdings in Colgate-Palmolive by 86.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after purchasing an additional 150 shares during the period. Triumph Capital Management grew its position in Colgate-Palmolive by 62.9% in the 4th quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after purchasing an additional 127 shares during the last quarter. Jessup Wealth Management Inc bought a new position in shares of Colgate-Palmolive during the 4th quarter worth about $26,000. Finally, Maseco LLP acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at about $27,000. 80.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on CL shares. Argus restated a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Raymond James Financial lowered their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research note on Monday, February 2nd. The Goldman Sachs Group restated a “buy” rating and set a $94.00 price target on shares of Colgate-Palmolive in a report on Saturday, January 31st. Finally, Rothschild & Co Redburn set a $93.00 price objective on Colgate-Palmolive in a report on Friday. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $94.38.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.